280 Hours to Rebuild a Medicaid Benefit in Every State

Deep in the collection-of-information section of a 212-page Medicaid final rule sits a number that prices the entire national implementation.

280 staff hours.

That is the whole build, as CMS scores it: fifty states, five territories and the District of Columbia, $28,394 all in, split evenly between the federal and state shares. Roughly five hours and $507 per jurisdiction.

CMS filed CMS-2451-F for public inspection Tuesday at 4:15pm ET as a special filing, scheduled to publish Thursday. It ends federal financial participation in Medicaid payment for a defined category of pharmaceutical and surgical interventions furnished to children under 18, and does the same in a separate CHIP for children under 19. CMS's own announcement puts the effective date at October 13.

So you have about eight weeks, and CMS thinks it takes an afternoon.

What the Regulation Text Actually Says

New subpart N lands at 42 CFR part 441, with a parallel section at 457.476 for CHIP.

Two sentences do the work. A state plan "must provide that the Medicaid agency will not make payment under the plan" for the covered services, and FFP "is not available in State expenditures" for them.

Then comes the part that decides what your edits look like.

The regulated category is defined by purpose, not by procedure. CMS states it plainly: "the same pharmaceutical or surgical intervention may or may not constitute a sex-rejecting procedure depending on the purpose for which it is provided." Three exclusions run off that same hinge, covering treatment of a medically verifiable disorder of sexual development, anything furnished "for purposes other than" the aligning purpose the rule describes, and treatment of complications.

There is no code list anywhere in the rule.

Six ICD-10 codes do appear (F64.0, F64.1, F64.2, F64.8, F64.9 and Z87.890), and they appear exactly once, inside the regulatory impact analysis, as the query CMS ran against T-MSIS to size its estimate. They are not the operative test, and the rule never claims they are. A commenter asked CMS "to clarify the role of diagnosis and procedure codes in implementing the rule to reduce inconsistent coverage determinations and appeals." CMS did not.